Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
PMN | ProMIS Neurosciences Inc. | Farfel Gail M | Chief Executive Officer | Dec 14, 2022 | Buy | $4.94 | 1,000 | 4,940 | 2,000 | Dec 16, 2022, 03:30 PM | |
PMN | ProMIS Neurosciences Inc. | Farfel Gail M | Chief Executive Officer | Dec 06, 2022 | Buy | $5.70 | 1,000 | 5,700 | 1,000 | Dec 08, 2022, 05:24 PM | |
DRRX | DURECT CORP | Farfel Gail M | Director | May 16, 2022 | Buy | $0.39 | 25,300 | 9,811 | 70,089 | May 18, 2022, 08:35 PM | |
DRRX | DURECT CORP | Farfel Gail M | Director | May 18, 2022 | Buy | $0.41 | 29,911 | 12,201 | 100,000 | May 18, 2022, 08:35 PM | |
DRRX | DURECT CORP | Farfel Gail M | Director | May 11, 2022 | Buy | $0.40 | 9,950 | 3,973 | 34,039 | May 13, 2022, 09:07 PM | |
DRRX | DURECT CORP | Farfel Gail M | Director | May 12, 2022 | Buy | $0.39 | 1,500 | 585 | 35,539 | May 13, 2022, 09:07 PM | |
DRRX | DURECT CORP | Farfel Gail M | Director | May 13, 2022 | Buy | $0.40 | 9,250 | 3,700 | 44,789 | May 13, 2022, 09:07 PM | |
DRRX | DURECT CORP | Farfel Gail M | Director | May 10, 2022 | Buy | $0.41 | 2,339 | 950 | 24,089 | May 12, 2022, 08:32 PM | |
DRRX | DURECT CORP | Farfel Gail M | Director | May 09, 2022 | Buy | $0.39 | 17,500 | 6,906 | 17,500 | May 10, 2022, 09:12 PM | |
DRRX | DURECT CORP | Farfel Gail M | Director | May 10, 2022 | Buy | $0.40 | 4,250 | 1,679 | 21,750 | May 10, 2022, 09:12 PM | |
ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Development Officer | Mar 15, 2021 | Option Exercise | $20.70 | 1,864 | 38,585 | 14,776 | Mar 17, 2021, 04:02 PM | |
ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Development Officer | May 12, 2020 | Sale | $28.21 | 2,573 | 72,584 | 5,048 | May 13, 2020, 05:39 PM | |
ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Development Officer | Mar 15, 2020 | Option Exercise | $22.01 | 1,221 | 26,874 | 7,621 | Mar 17, 2020, 07:24 PM | |
ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Development Officer | Aug 22, 2019 | Sale | $52.00 | 3,446 | 179,192 | 4,891 | Aug 23, 2019, 04:09 PM | |
ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Development Officer | Mar 15, 2019 | Option Exercise | $51.88 | 488 | 25,317 | 8,337 | Mar 19, 2019, 06:59 PM | |
ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Development Officer | Oct 04, 2018 | Sale | $28.60 | 13,922 | 398,104 | 14,104 | Oct 09, 2018, 05:37 PM | |
ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Development Officer | Sep 04, 2018 | Sale | $30.77 | 14,000 | 430,762 | 14,143 | Sep 05, 2018, 04:14 PM | |
ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Development Officer | Aug 08, 2018 | Sale | $33.29 | 14,000 | 466,033 | 14,143 | Aug 10, 2018, 04:06 PM | |
ZGNX | ZOGENIX, INC. | Farfel Gail M | EVP/Chief Development Officer | Jun 12, 2018 | Option Exercise | $29.66 | 10,118 | 300,110 | 12,261 | Jun 13, 2018, 08:57 PM | |
MRNS | MARINUS PHARMACEUTICALS INC | Farfel Gail M | Chief Clinical Dev & Reg Offic | Apr 21, 2015 | Option Exercise | $5.26 | 60,000 | 315,711 | 30,000 | Apr 23, 2015, 04:48 PM |